47 filings
8-K
MIRA
Mira Pharmaceuticals Inc
19 Jul 24
Other Events
5:12pm
8-K
MIRA
Mira Pharmaceuticals Inc
12 Jul 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
MIRA
Mira Pharmaceuticals Inc
28 Jun 24
Departure of Directors or Certain Officers
5:00pm
8-K
MIRA
Mira Pharmaceuticals Inc
29 May 24
Departure of Directors or Certain Officers
8:30am
10-Q
2024 Q1
MIRA
Mira Pharmaceuticals Inc
Quarterly report
13 May 24
4:31pm
10-K
ovdzj64cs1 p87k08zx
1 Apr 24
Annual report
7:00am
8-K
7gy0y17dbl29xhm6hq
13 Mar 24
Departure of Directors or Certain Officers
4:30pm
8-K
fzgc8grsou2f
7 Mar 24
Other Events
4:45pm
8-K
b9qh63cm05z8jvr uykn
17 Jan 24
Departure of Directors or Certain Officers
4:30pm
EFFECT
qsnk64n2dam9v7sb1q
28 Dec 23
Notice of effectiveness
12:15am
UPLOAD
2gvlk5oakgl
22 Dec 23
Letter from SEC
12:00am
CORRESP
scefzd2izv
22 Dec 23
Correspondence with SEC
12:00am
8-K
ixrfesa tzuku
1 Dec 23
Departure of Directors or Certain Officers
5:00pm
8-K
lvn2obvg05h4n657
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
424B3
g9rz6bj9
13 Nov 23
Prospectus supplement
6:57pm
8-K
adtacnf6f qzhv
25 Oct 23
Departure of Directors or Certain Officers
4:45pm
424B3
0r7g62ld
18 Sep 23
Prospectus supplement
5:00pm
10-Q
g6h ztyhiv
15 Sep 23
Quarterly report
4:45pm